388
Views
22
CrossRef citations to date
0
Altmetric
Research Article

2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense

&
Pages 1446-1457 | Received 07 Apr 2012, Accepted 23 Aug 2012, Published online: 01 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Claudia Geismann, Alexander Arlt, Susanne Sebens & Heiner Schäfer. (2014) Cytoprotection “gone astray”: Nrf2 and its role in cancer. OncoTargets and Therapy 7, pages 1497-1518.
Read now

Articles from other publishers (21)

Barbara Marengo, Josè Pedro Friedmann Angeli & Cinzia Domenicotti. (2023) Editorial: Redox metabolism: a double edge sword sustaining the adaptive resistance to therapy in cancer. Frontiers in Oncology 13.
Crossref
Yuichiro Matsuoka, Ryoji Yoshida, Kenta Kawahara, Junki Sakata, Hidetaka Arita, Hikaru Nkashima, Nozomu Takahashi, Masatoshi Hirayama, Masashi Nagata, Akiyuki Hirosue, Yoshikazu Kuwahara, Manabu Fukumoto, Ryo Toya, Ryuji Murakami & Hideki Nakayama. (2022) The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation. Laboratory Investigation 102:8, pages 896-907.
Crossref
Isabell Goetting, Safa Larafa, Katharina Eul, Mikhail Kunin, Burkhard Jakob, Johann Matschke & Verena Jendrossek. (2022) Targeting AKT-Dependent Regulation of Antioxidant Defense Sensitizes AKT-E17K Expressing Cancer Cells to Ionizing Radiation. Frontiers in Oncology 12.
Crossref
Arzu Öztürk Kesebir, Pınar Güller, Ramazan Kalın, Hasan Özdemir & Ömer İrfan Küfrevioğlu. (2022) Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results. Biotechnology and Applied Biochemistry 69:3, pages 1275-1283.
Crossref
Dhananjay Kumar Sah, Yogesh Rai, Ankit Chauhan, Neeraj Kumari, Madan Mohan Chaturvedi & Anant Narayan Bhatt. (2021) Sphingosine kinase inhibitor, SKI-II confers protection against the ionizing radiation by maintaining redox homeostasis most likely through Nrf2 signaling. Life Sciences 278, pages 119543.
Crossref
María Florencia Arbe, Lucrecia Agnetti, Elizabeth Breininger, Gerardo Claudio Glikin, Liliana María Elena Finocchiaro & Marcela Solange Villaverde. (2020) Glucose 6-phosphate dehydrogenase inhibition sensitizes melanoma cells to metformin treatment. Translational Oncology 13:11, pages 100842.
Crossref
Felix Christian Hasse, Stefan Alexander Koerber, Elena Sophie Prigge, Jakob Liermann, Magnus von Knebel Doeberitz, Juergen Debus & Florian Sterzing. (2019) Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation. Clinical and Translational Radiation Oncology 19, pages 52-58.
Crossref
Anna Belanova, Darya Beseda, Victor Chmykhalo, Alisa Stepanova, Mariya Belousova, Vera Khrenkova, Nikolaos Gavalas & Peter Zolotukhin. (2019) Berberine Effects on NFκB, HIF1A and NFE2L2/AP-1 Pathways in HeLa Cells. Anti-Cancer Agents in Medicinal Chemistry 19:4, pages 487-501.
Crossref
Olivier Pluquet & Antoine Galmiche. (2019) Impact and Relevance of the Unfolded Protein Response in HNSCC. International Journal of Molecular Sciences 20:11, pages 2654.
Crossref
Xiaofei ChenJade MimsXiumei HuangNaveen SinghEdward MoteaSarah M. PlanchonMuhammad BegAllen W. TsangMercedes PorosnicuMelissa L. KempDavid A. BoothmanCristina M. Furdui. (2018) Modulators of Redox Metabolism in Head and Neck Cancer. Antioxidants & Redox Signaling 29:16, pages 1660-1690.
Crossref
Heng Jiang, Hui Wang & Mark De Ridder. (2018) Targeting antioxidant enzymes as a radiosensitizing strategy. Cancer Letters 438, pages 154-164.
Crossref
Xiaoyi Chen, Zhijie Xu, Zhijian Zhu, Anqi Chen, Guanghou Fu, Yimin Wang, Hao Pan & Baiye Jin. (2018) Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro. International Journal of Oncology.
Crossref
Deepika Arora, Mohammed Haris Siddiqui, Pradeep Kumar Sharma & Yogeshwer Shukla. (2016) Deltamethrin induced RIPK3-mediated caspase-independent non-apoptotic cell death in rat primary hepatocytes. Biochemical and Biophysical Research Communications 479:2, pages 217-223.
Crossref
Jonathan E. Schoenhals, Steven N. Seyedin, Chad Tang, Maria A. Cortez, Sharareh Niknam, Efrosini Tsouko, Joe Y. Chang, Stephen M. Hahn & James W. Welsh. (2016) Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy. The Cancer Journal 22:2, pages 130-137.
Crossref
Jing Lv, Jieqiong Wang, Siyu Chang, Mingyao Liu & Xiufeng Pang. (2016) The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?. Acta Biochimica et Biophysica Sinica 48:1, pages 17-26.
Crossref
Mingfei Zhao, Hangdi Xu, Buyi Zhang, Bo Hong, Wei Yan & Jianmin Zhang. (2015) Impact of nuclear factor erythroid-derived 2–like 2 and p62/sequestosome expression on prognosis of patients with gliomas. Human Pathology 46:6, pages 843-849.
Crossref
Jade Mims, Nidhi Bansal, Manish S. Bharadwaj, Xiaofei Chen, Anthony J. Molina, Allen W. Tsang & Cristina M. Furdui. (2015) Energy Metabolism in a Matched Model of Radiation Resistance for Head and Neck Squamous Cell Cancer. Radiation Research 183:3, pages 291-304.
Crossref
JIANHONG ZHU, HANDONG WANG, YOUWU FAN, YIXING LIN, LI ZHANG, XIANGJUN JI & MENGLIANG ZHOU. (2014) Targeting the NF-E2-related factor 2 pathway: A novel strategy for glioblastoma (Review). Oncology Reports 32:2, pages 443-450.
Crossref
Y. Zhang & S.G. Martin. (2014) Redox Proteins and Radiotherapy. Clinical Oncology 26:5, pages 289-300.
Crossref
Prudence Donovan, Kathleen Cato, Roxane Legaie, Rumal Jayalath, Gemma Olsson, Bruce Hall, Sarah Olson, Samuel Boros, Brent A. Reynolds & Angus Harding. (2014) Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors. Mol. BioSyst. 10:4, pages 741-758.
Crossref
Suna Zhou, Wenguang Ye, Qiuju Shao, Mingxin Zhang & Jun Liang. (2013) Nrf2 is a potential therapeutic target in radioresistance in human cancer. Critical Reviews in Oncology/Hematology 88:3, pages 706-715.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.